Users' preferences and perceptions of the comprehensibility and readability of medication labels.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 15 04 2018
accepted: 29 01 2019
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 13 11 2019
Statut: epublish

Résumé

To evaluate the labeling preferences of medication users and characterize their perceptions of the comprehensibility and readability of medication labels. We conducted a population-based cross-sectional study of medication users aged 18 years or older in 10 Brazilian capital cities. Perceptions of the comprehensibility and readability of medication labels in relation to sociodemographic characteristics were evaluated by Poisson regression models with robust variance. Labeling preferences were assessed through questions addressing possible improvements and through the use of digitally simulated packages. Of 6,255 medication users interviewed, more than half found it difficult or very difficult to read (50.8%) and/or understand (52.0%) medication labels. Difficulties were more pronounced for participants aged 40 years or older, with lower levels of education, and non-whites. Increasing the font size (93.7%), describing the indications for use (95.9%) and contraindications (95.6%) on the label, and highlighting the expiration date (96.3%) were the most widely accepted improvements. In the evaluation of simulated packages, users preferred factors that improved readability, such as increased font size, use of graphic elements and color to highlight the concentration of the active ingredient, and contrast between the font color and background. The new simulated package design, with increased font size, color to highlight the concentration and contrast between the font color and background, was preferred over the standard design by 77.0% of participants. Based on users' perceptions, increased font size and use of graphic elements and color to emphasize critical information, such as expiration date and concentration, are factors that contribute to making medication labels clearer to users. Pharmaceutical industries and policy makers should consider these items when developing labels and defining policies on this issue.

Identifiants

pubmed: 30794574
doi: 10.1371/journal.pone.0212173
pii: PONE-D-18-11318
pmc: PMC6386266
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0212173

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Contemp Clin Trials. 2010 Nov;31(6):564-71
pubmed: 20647058
Health Expect. 2007 Sep;10(3):286-98
pubmed: 17678517
Patient Educ Couns. 2007 Aug;67(3):293-300
pubmed: 17587533
Hum Factors. 2016 Dec;58(8):1206-1216
pubmed: 27591209
J Patient Saf. 2010 Sep;6(3):158-64
pubmed: 21491790
J Patient Saf. 2013 Sep;9(3):122-8
pubmed: 23860193
Ergonomics. 2003 Mar 15;46(4):327-44
pubmed: 12637173
J Med Syst. 2004 Feb;28(1):9-29
pubmed: 15171066
Appl Ergon. 2006 Jul;37(4):491-500
pubmed: 16753132
J Clin Psychol Med Settings. 1994 Jun;1(2):149-59
pubmed: 24227289
Arch Intern Med. 2007 Sep 10;167(16):1760-5
pubmed: 17846395
Int J Ind Ergon. 2011 Jul 1;41(4):394-399
pubmed: 21731156
Ergonomics. 2006 Apr 15-May 15;49(5-6):617-30
pubmed: 16717013
Ann Pharmacother. 2003 Feb;37(2):259-67
pubmed: 12549958

Auteurs

Emilia da Silva Pons (EDS)

Proadi-SUS Research Projects Office, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.

Cassia Garcia Moraes (CG)

Proadi-SUS Research Projects Office, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.

Maicon Falavigna (M)

Proadi-SUS Research Projects Office, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.

Lisana Reginini Sirtori (LR)

GGREG-General Management Office for Regulations and Good Regulatory Practices, Brazilian Health Regulatory Agency (ANVISA), Brasília, DF, Brazil.

Fernanda da Cruz (F)

General Management Office for Health Inspection and Surveillance, ANVISA, Brasília, DF, Brazil.

Guilherme Webster (G)

Independent Graphic Designer, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.

Tatiane da Silva Dal Pizzol (TDS)

Department of Production and Control of Medicines, School of Pharmacy, UFRGS, Porto Alegre, RS, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH